Multicenter phase I dose escalation and expansion study of pyrotinib in combination with camrelizumab and chemotherapy as first-line treatment for HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma
吡咯替尼联合卡瑞利珠单抗和化疗作为HER2阳性晚期胃癌和胃食管交界处腺癌一线治疗的多中心I期剂量递增和扩展研究
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2023.102314
Li, Sheng; Bao, Jun; Li, Xiaoyou; Yang, Quanliang; Xu, Junying; Chen, Surong; Feng, Ge; Gao, Chao; Feng, Lin; Lu, Bin; Miao, Min; Ni, Xinchu; Wang, Guofang; Yang, Lei; Zhu, Liangjun